ACULAR PRESERVATIVE FREE
LOE ApproachingNDAOPHTHALMICSOLUTION/DROPS
Approved
Nov 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ACULAR PRESERVATIVE FREE is a preservative-free ophthalmic solution approved by the FDA in 1997. The product is formulated for topical ocular administration and represents a specialized formulation of an established ophthalmic therapy. It addresses patient needs for preservative-free eye drop delivery in ophthalmology.
LOE Approaching
As an LOE-approaching product, the brand team is likely consolidating operations and transitioning focus to lifecycle extension or other portfolio assets.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ACULAR PRESERVATIVE FREE offers limited career growth trajectory given its LOE-approaching status and zero linked job openings. This role is best suited for professionals seeking stability in a mature franchise or transitional assignments within a larger portfolio.
Brand ManagerField Sales Representative
Worked on ACULAR PRESERVATIVE FREE at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.